L. Sarmati

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
L Sarmati, L. Sarmati, Loredana Sarmati
Publication record
388 papers · 6,196 citations · H-index 40

PAPERS

CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae.
20260 citationsauthor #19
LBP-036-YI Suboptimal performances of Baveno VII and AASLD 2024 criteria for detecting clinically significant portal hypertension with varices in untreated patients with HDV cirrhosis
20250 citationsauthor #19
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME project
20251 citationsauthor #40
COVID-19 and influenza vaccination among adults stably engaged in HIV care
20250 citationsauthor #8
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status
20250 citationsauthor #10
Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro.
20251 citationsauthor #107
Treatment of Condyloma Acuminata with Tirbanibulin 1% Ointment in People Living with HIV: A Case Series with Literature Review
20250 citationsauthor #5
Herpes Simplex Virus Pneumonia in Immunocompetent Patients Undergoing Cardiac Surgery: Case Series.
20250 citationsauthor #12
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry
20250 citationsauthor #130
The transactivation of human endogenous retroviruses is associated with HIV-1 reservoir, lymphocyte activation and low CD4 count in virologically suppressed PLWH.
20251 citationsauthor #17
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era
20252 citationsauthor #32
Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis.
20251 citationsauthor #10
OS-015 The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-european level
20251 citationsauthor #36
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation
20251 citationsauthor #160
COVID‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features
20250 citationsauthor #11
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
20255 citationsauthor #22
Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in Pseudomonas aeruginosa isolates in a tertiary hospital
20253 citationsauthor #13
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry
20251 citationsauthor #7
WED-285-YI Real-world evidence shows comparable Bulevirtide effectiveness in hepatitis D patients with and without cirrhosis: results from the prospective nationwide D-Shield multicenter study
20252 citationsauthor #14
Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis
20250 citationsauthor #3
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database
20251 citationsauthor #20
P-771. Demographic and Clinical Characteristics of Adverse Reactions to anti-Tuberculosis Therapy: A Retrospective Analysis
20250 citationsauthor #12
OS-072-YI HBV integration can sustain HDV persistence especially in the setting of an absent HBV reservoir and can be a biomarker of response to bulevirtide
20250 citationsauthor #25
Characterisation of four novel bacteriophages targeting carbapenem-resistant Klebsiella pneumoniae and their lytic activity alone and in combination
20251 citationsauthor #14
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation
20250 citationsauthor #8
Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids
20250 citationsauthor #14
The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
20251 citationsauthor #9
Comparative Analysis of Early COVID‐19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials
20250 citationsauthor #30
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature
20243 citationsauthor #17
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study
202429 citationsauthor #26
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
20244 citationsauthor #24
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
20242 citationsauthor #12
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis
20244 citationsauthor #8
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21
20248 citationsauthor #21
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic
20241 citationsauthor #9
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study
202426 citationsauthor #17
Histoplasmosis in patients living with HIV in Europe: review of literature
202412 citationsauthor #13
Incidence and predictors of clinical failure after early treatment for mild‐to‐moderate COVID‐19 in high‐risk individuals: A multicentric cohort study
20243 citationsauthor #6
HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch
20244 citationsauthor #12
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
20245 citationsauthor #4
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
202417 citationsauthor #11
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence
20244 citationsauthor #8
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves.
20242 citationsauthor #17
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection
20242 citationsauthor #26
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study
20240 citationsauthor #14
FRI-392-YI Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV monoinfection, that parallels HDV replicative and cytolytic activity
20241 citationsauthor #18
Kinetics of Hepatitis B Virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to Tenofovir sparing therapy.
20245 citationsauthor #13
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review
20236 citationsauthor #15
Multishell diffusion MRI reveals whole‐brain white matter changes in HIV
20234 citationsauthor #6
Human Arboviral Infections in Italy: Past, Current, and Future Challenges
202314 citationsauthor #14
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
202313 citationsauthor #22
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients
20236 citationsauthor #9
Pillars of long-term antiretroviral therapy success.
202318 citationsauthor #37
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience
20233 citationsauthor #11
Human African Trypanosomiasis (sleeping sickness): Current knowledge and future challenges
202337 citationsauthor #21
Application of Phage Therapy in a Case of a Chronic Hip-Prosthetic Joint Infection due to Pseudomonas aeruginosa: An Italian Real-Life Experience and In Vitro Analysis
202345 citationsauthor #9
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli
20230 citationsauthor #31
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing
20234 citationsauthor #23
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy
20235 citationsauthor #14
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients
20232 citationsauthor #13
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir
20230 citationsauthor #22
Parietal resting-state EEG alpha source connectivity is associated with subcortical white matter lesions in HIV-positive people.
20230 citationsauthor #17
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review
20235 citationsauthor #6
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
20236 citationsauthor #18
New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
202311 citationsauthor #7
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage
20230 citationsauthor #17
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection
202312 citationsauthor #16
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli
20231 citationsauthor #31
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections
20234 citationsauthor #18
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication.
20237 citationsauthor #34
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
202311 citationsauthor #14
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study
20231 citationsauthor #14
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves
20237 citationsauthor #17
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study
202316 citationsauthor #11
2169. A 4-Year Analysis of Antimicrobial Susceptibility to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: How Drug Availability Affects Resistance Rate
20230 citationsauthor #9
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
20237 citationsauthor #18
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
202318 citationsauthor #13
In the setting of HIV-infection, HBV-reactivation is revealed by highly sensitive assays in a conspicuous fraction of anti-HBc-positive/HBsAg-negative patients switching to Tenofovir-sparing therapy
20222 citationsauthor #11
1045. Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production
20220 citationsauthor #15
Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization
20228 citationsauthor #19
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy
202214 citationsauthor #49
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
20227 citationsauthor #12
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients
20221 citationsauthor #21
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production
202216 citationsauthor #20
Microbiology and Clinical Outcome of Hospital-Acquired Respiratory Infections in an Italian Teaching Hospital: A Retrospective Study
20228 citationsauthor #9
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients
202224 citationsauthor #15
1438. Latent tuberculosis infection (LTBI) in hematopoietic stem cell transplantation (HSCT) recipients: a retrospective Italian cohort study in Tor Vergata University Hospital, Rome.
20221 citationsauthor #8
Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient
20222 citationsauthor #7
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
20225 citationsauthor #21
2071. HIV reservoir evaluation in GALT and PBMCs of virologically suppressed patients
20220 citationsauthor #13
Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey.
20228 citationsauthor #6
Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)
20225 citationsauthor #29
280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
20220 citationsauthor #11
Antimicrobial resistance in the times of COVID-19 in a roman teaching hospital
20223 citationsauthor #8
Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine
20221 citationsauthor #16
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice.
202213 citationsauthor #14
PARIETAL INTRAHEMISPHERIC SOURCE CONNECTIVITY OF RESTING-STATE ELECTROENCEPHALOGRAPHIC ALPHA RHYTHMS IS ABNORMAL IN NAÏVE HIV PATIENTS.
20222 citationsauthor #14
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors
202245 citationsauthor #6
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
202240 citationsauthor #19
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome
20227 citationsauthor #14

TIMELINE

1990 0 citations

1992 17 citations

1994 12 citations

1995 11 citations

1996 33 citations

1997 60 citations

1998 10 citations

1999 312 citations

2000 154 citations

2001 339 citations

2002 295 citations

2003 185 citations

2004 172 citations

2005 417 citations

2006 2 citations

2007 193 citations

2008 34 citations

2009 102 citations

2010 165 citations

2011 121 citations

2012 255 citations

2013 263 citations

2014 169 citations

2015 290 citations

2016 212 citations

2017 337 citations

2018 123 citations

2019 229 citations

2020 529 citations

2021 489 citations

2022 256 citations

2023 263 citations

2024 132 citations

2025 22 citations

2026 0 citations

L. Sarmati

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT